These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3125812)

  • 41. Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a 2-year experience.
    Dinh H; Baker BJ; de Soyza N; Murphy ML
    Am Heart J; 1988 Jan; 115(1 Pt 1):92-6. PubMed ID: 3336989
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Propafenone for refractory ventricular arrhythmias: correlation with drug plasma levels during long-term treatment.
    Naccarella F; Bracchetti D; Palmieri M; Marchesini B; Ambrosioni E
    Am J Cardiol; 1984 Nov; 54(8):1008-14. PubMed ID: 6496321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rate-dependent failure of ventricular capture in patients treated with oral propafenone.
    Soriano J; Almendral J; Arenal A; San Román D; Delcan JL; Josephson ME
    Eur Heart J; 1992 Feb; 13(2):269-74. PubMed ID: 1555627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre study.
    Geibel A; Meinertz T; Zehender M; Vitak J; Hohnloser S; Kunz-Fritze A; Just H
    Eur Heart J; 1989 Sep; 10 Suppl E():81-7. PubMed ID: 2680506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Ventricular tachycardia of the infant. 2 new cases].
    Clémenty J; Choussat A; Saint-Martin J; Giraudet C; Dallocchio M; Bricaud H
    Arch Mal Coeur Vaiss; 1976 Mar; 69(3):321-31. PubMed ID: 828018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical effects and plasma concentration levels of aprindine hydrochloride in patients with tachyarrhythmias].
    Kasahara S; Shibata N; Mizobe H; Shoda M; Miyazaki Y; Miura M; Miyazawa Y; Komatsu Y
    Kokyu To Junkan; 1989 Nov; 37(11):1225-30. PubMed ID: 2602679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immediate reproducibility of clinical and nonclinical forms of induced ventricular tachycardia.
    de Buitleir M; Morady F; DiCarlo LA; Baerman JM; Krol RB
    Am J Cardiol; 1986 Aug; 58(3):279-82. PubMed ID: 3739917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustained ventricular tachycardia occurring during propafenone therapy.
    De Jaegere P; Huyghens L; Dewilde P
    Acta Cardiol; 1987; 42(3):207-12. PubMed ID: 3499736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Normal left ventricular function does not protect against propafenone-induced incessant ventricular tachycardia.
    Millar RN; Lawrenson JB; Milne DA
    S Afr Med J; 1993 Apr; 83(4):256-9. PubMed ID: 8316922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ventricular tachycardia during theophylline overdose. Apropos of a case of reduction by magnesium chloride].
    Chevalier B; le Heuzey JY; Colombel B; Lavergne T; Guize L; Rozensztajn L; Valty J
    Arch Mal Coeur Vaiss; 1990 Apr; 83(4):569-73. PubMed ID: 2111681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy.
    Steurer G; Weber H; Schmidinger H; Plass H; Frey B; Pürerfellner H; Probst P
    Eur Heart J; 1991 Apr; 12(4):526-32. PubMed ID: 2065687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propafenone for malignant ventricular arrhythmia: an analysis of the literature.
    Hernandez M; Reder RF; Marinchak RA; Rials SJ; Kowey PR
    Am Heart J; 1991 Apr; 121(4 Pt 1):1178-84. PubMed ID: 2008842
    [No Abstract]   [Full Text] [Related]  

  • 55. Serum digoxin levels related to plasma propafenone levels during concomitant treatment.
    Bigot MC; Debruyne D; Bonnefoy L; Grollier G; Moulin M; Potier JC
    J Clin Pharmacol; 1991 Jun; 31(6):521-6. PubMed ID: 1880217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exacerbation of myasthenia by propafenone.
    Lecky BR; Weir D; Chong E
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):377. PubMed ID: 2056335
    [No Abstract]   [Full Text] [Related]  

  • 57. Ventricular Tachycardia in Association with Propafenone Overdose.
    Kim HK; Kim SS; Ki YJ; Park KH; Choi DH
    Acta Cardiol Sin; 2021 Jan; 37(1):100-103. PubMed ID: 33488033
    [No Abstract]   [Full Text] [Related]  

  • 58. Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim.
    Trebach J; Mohan S; Hoffman RS
    Acta Cardiol Sin; 2021 May; 37(3):324. PubMed ID: 33976520
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply to the Letter to the Editor for the Article Entitled「Response to "Ventricular Tachycardia in Association with Propafenone Overdose" by Hyun Kuk Kim」.
    Kim HK; Kim SS; Ki YJ; Park KH; Choi DH
    Acta Cardiol Sin; 2021 May; 37(3):329. PubMed ID: 33978637
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of ventricular tachycardia with propafenone. Parallel study of ventricular provocation tests].
    Faućhier JP; Rouesnel P; Cosnay P; Moquet B; Huguet R; Van Viet H; Balleh H
    Arch Mal Coeur Vaiss; 1987 Sep; 80(10):1523-31. PubMed ID: 3125812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.